Search

The legal departments of Guangdong, Hong Kong, and Macao have jointly released a unified, high-standard talent directory, marking the first systematic establishment of a regional legal professionals database. This initiative goes beyond a mere compilation of personnel, serving as a key institutional step toward aligning regulations and creating a "Greater Bay Area standard." It reflects substantive progress in building an international and law-based business environment in the region, providing clear and predictable cross-border dispute resolution safeguards for market entities, including Hong Kong businesses.

The "Hong Kong and Macao Drug and Medical Device Access" policy in the Guangdong-Hong Kong-Macao Greater Bay Area has recently added 27 designated mainland medical institutions, covering cities such as Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Huizhou, Zhuhai, and Zhaoqing. This measure brings the total number of designated mainland medical institutions in the Greater Bay Area to 71, further facilitating cross-border access to advanced drugs and medical devices already available in Hong Kong and Macao for residents of the region, and promoting deeper integration in medical services.

The Hong Kong SAR Government has established the "Hung Shui Kiu Industrial Park Company Limited" to accelerate industrial development in the Northern Metropolis. This initiative leverages Hung Shui Kiu's strategic location adjacent to Qianhai and its connectivity within the Greater Bay Area. Through diverse public-private partnership models, it focuses on attracting and supporting Hong Kong businesses in developing high-value-added industries, providing a crucial platform for their expansion into the Greater Bay Area market.

The Hong Kong IPO market saw strong performance in 2025, reclaiming the global top position with estimated fundraising surpassing HKD 286.3 billion from 117 new listings. Two structural trends stood out: rising "A-share content" with 19 mainland listings contributing nearly half of total proceeds (including six "A+H" firms in the top 10 IPOs), and growing "innovation momentum" led by hard-tech and new-consumer companies, featuring 17 Chapter 18A biotech and five Chapter 18C specialized tech listings. The year also recorded a five-year low IPO debut discount rate and HKD 1.41 trillion in net southbound capital inflows.

Driven by Hong Kong's strong export growth in 2025 and robust demand for artificial intelligence products, the Hong Kong Trade Development Council forecasts that merchandise exports are expected to continue growing by 8–9% in 2026. This will have a positive ripple effect on the Greater Bay Area’s supply chain. The report also highlights that the Chinese mainland, as Hong Kong's primary export market and expansion focus, will continue to provide crucial support to manufacturing and trading enterprises in the region.

The latest Export Index from the Hong Kong Trade Development Council shows that exporters remain cautiously optimistic about business prospects in the fourth quarter of 2025. The survey specifically notes that the Chinese mainland and ASEAN are the most promising export markets for the future. This provides valuable insights for Greater Bay Area enterprises in seizing opportunities arising from regional economic and trade integration, aiding them in planning their market expansion strategies.

The "Funding Scheme for Promoting Industrial Development and Technological Innovation" will accept applications from January 1 to 21, 2026. It provides grants to Macau enterprises and institutions for tech innovation and industrial projects, supporting local industrial upgrading and integration into the Greater Bay Area.

The Guangdong-Hong Kong-Macao Greater Bay Area is cultivating new quality productive forces through integrated "land, sea, and air" innovation. By strategically advancing fields such as AI, RISC-V chips, marine technology, and the low-altitude economy, backed by long-term patient capital, it is building a globally influential international science and technology innovation center.

Recently, the National Venture Capital Guiding Fund was officially launched, with one of its first three regional funds established in the Greater Bay Area. Focused on “patient capital” for hard tech—such as integrated circuits and AI—it targets seed and early-stage startups, fostering new quality productive forces to advance regional innovation.

The Guangdong-Hong Kong-Macao Greater Bay Area Water Technology Innovation Centre was inaugurated to address regional water security through tripartite collaboration and technologies like AI. It offers Hong Kong businesses opportunities to integrate IoT and big data expertise with mainland smart-water markets for industrial application.

The national Venture Capital Guiding Fund has been launched, with its sub-fund, the Guangdong-Hong Kong-Macao Greater Bay Area Venture Capital Guiding Fund, established in Shenzhen. The fund, with a target scale exceeding RMB 50 billion and a lifespan of 20 years, aims to provide patient capital to support early-stage and startup companies in hard-tech sectors such as integrated circuits and artificial intelligence, injecting key financial momentum into building the Greater Bay Area into an international science and technology innovation hub.

Recently, Guangdong launched the country's first provincial-level low-altitude economy talent cultivation service platform. Built on a "1+2+5" model, it aims to connect the Greater Bay Area's low-altitude economy industry with interdisciplinary talent, accurately address supply-demand mismatches, and strengthen the talent foundation for industrial development.

Guangdong has issued the "Work Plan for Promoting Financial Services to Support the Building of a Strong Technology Province," aiming to establish a financial support system covering the entire technology innovation chain. The plan designates the Guangdong-Hong Kong-Macao Greater Bay Area as the core region, focusing on its leading industries. By deepening the QFLP pilot and supporting listings in Hong Kong, it strengthens cross-border financial connectivity, injecting key financial momentum into building the Greater Bay Area into an international innovation hub.

The Guangdong-Hong Kong-Macao Greater Bay Area International Clinical Trial Institute has taken a new step forward with the launch of a real-world research and application center. The center will integrate regional healthcare data (including data from the “Hong Kong and Macao Drug and Medical Device Access Policy”) and has simultaneously activated the Greater Bay Area Clinical Trial Collaboration Platform. This initiative aims to accelerate the development and approval of innovative drugs and medical devices, promote data connectivity, leverage Hong Kong’s role as a “super-connector,” and establish the Hetao area as a key gateway for the commercialization of biomedical innovations.

Guangdong has released its "15th Five-Year Plan" proposals, focusing on building the Greater Bay Area into an international innovation hub. Hong Kong businesses should leverage their strengths, integrate with the region's industrial chains, and explore opportunities in sectors like new energy and AI, as well as in key zones such as Nansha and Hetao.